Metabolism-Clinical and Experimental

METABOLISM-CLINICAL AND EXPERIMENTAL, abbreviated as METABOLISM, is a leading peer-reviewed journal dedicated to advancing the understanding of metabolic processes and their clinical implications. With an ISSN of 0026-0495 and a formidable 2026 Impact Factor of 16.700, it holds a distinguished position in the JCR Q1 quartile, reflecting its exceptional influence and high citation impact within the fields of endocrinology, diabetes, and metabolism. The journal’s scope encompasses a broad spectrum of topics, including but not limited to energy homeostasis, obesity, insulin resistance, lipid metabolism, mitochondrial function, and the metabolic underpinnings of cardiovascular disease, cancer, and aging. It publishes a range of article types, including original research articles, comprehensive reviews, rapid communications, and editorials, all of which undergo rigorous peer review to ensure scientific excellence. The target audience is primarily comprised of clinical and basic science researchers, endocrinologists, diabetologists, nutritionists, and healthcare professionals seeking cutting-edge insights into metabolic disease mechanisms and therapeutic interventions. Published by Elsevier, METABOLISM offers both subscription and open access options, allowing authors to maximize the visibility and accessibility of their work. Notably, the journal is renowned for its highly cited special issues and thematic reviews that synthesize emerging evidence, making it an indispensable resource for the global metabolic research community. Its sustained Q1 ranking and impact factor well above 10 underscore its status as a premier venue for landmark studies in translational and clinical metabolism.